Healthcare - Biotechnology - NASDAQ - US
$ 0.4535
-1.26 %
$ 11.4 M
Market Cap
-0.44
P/E
CASH FLOW STATEMENT
-32 M
OPERATING CASH FLOW
38.4 M
INVESTING CASH FLOW
-11.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sensei Biotherapeutics, Inc.
| Net Income | -34.1 M |
| Depreciation & Amortization | 1.35 M |
| Capital Expenditures | -180 K |
| Stock-Based Compensation | 4.45 M |
| Change in Working Capital | -4.33 M |
| Others | -1.4 M |
| Free Cash Flow | -32.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (34.1) | (48.6) | (36.8) | (20.1) | (16.7) | (13.0) |
| Depreciation & Amortization | 1.4 | 1.3 | 0.7 | 0.2 | 73 K | 44 K |
| Deferred Income Tax | 0 | 0 | 19 K | (1.0) | 2.0 | 0 |
| Stock Based Compensation | 4.5 | 5.8 | 5.7 | 1.5 | 1.2 | 1.2 |
| Other Operating Activities | 0.6 | 1.4 | 57 K | 2.1 | 1.5 | 0.3 |
| Change in Working Capital | (4.3) | 1.0 | 0.1 | (0.4) | 3.5 | 1.5 |
| Cash From Operations | (32.0) | (39.0) | (30.3) | (17.7) | (8.6) | (10.3) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.2) | (0.3) | (2.0) | (1.2) | 53 K | 31 K |
| Other Items | 38.6 | 50.3 | (141.1) | (0.2) | 0 | 0 |
| Cash From Investing Activities | 38.4 | 49.9 | (143.1) | (1.4) | 53 K | 31 K |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | (10.4) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.8) | (0.6) | (0.3) | 0.5 | 8.1 | 0.8 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 28 K | 0 | 23.6 | 34.9 | 0.2 | 0 |
| Cash From Financing Activities | (11.2) | (0.3) | 0.2 | 35.5 | 8.2 | 0.8 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (4.8) | 10.6 | (9.4) | 16.3 | (0.4) | (9.6) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (32.2) | (39.3) | (32.3) | (18.9) | (8.6) | (10.3) |